Dr. Thomas J. Saphner
Claim this profileAurora Saint Luke's Medical Center
Studies Breast Cancer
Studies Cancer
30 reported clinical trials
68 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
ER negative
2Cancer
KRAS positive
Stage IV
BRAF positive
Affiliated Hospitals
Clinical Trials Thomas J. Saphner is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
More about Thomas J. Saphner
Clinical Trial Related2 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 16 Active Clinical TrialsTreatments Thomas J. Saphner has experience with
- Biospecimen Collection
- Pembrolizumab
- Questionnaire Administration
- Lenalidomide
- Therapeutic Conventional Surgery
- Binimetinib
Breakdown of trials Thomas J. Saphner has run
Breast Cancer
Cancer
Breast cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas J. Saphner specialize in?
Thomas J. Saphner focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Thomas J. Saphner currently recruiting for clinical trials?
Yes, Thomas J. Saphner is currently recruiting for 16 clinical trials in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Thomas J. Saphner has studied deeply?
Yes, Thomas J. Saphner has studied treatments such as Biospecimen Collection, Pembrolizumab, Questionnaire Administration.
What is the best way to schedule an appointment with Thomas J. Saphner?
Apply for one of the trials that Thomas J. Saphner is conducting.
What is the office address of Thomas J. Saphner?
The office of Thomas J. Saphner is located at: Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin 53215 United States. This is the address for their practice at the Aurora Saint Luke's Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.